{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T08:19:52Z","timestamp":1773389992303,"version":"3.50.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2009,4,2]],"date-time":"2009-04-02T00:00:00Z","timestamp":1238630400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Dermatol"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1186\/1471-5945-9-3","type":"journal-article","created":{"date-parts":[[2009,4,2]],"date-time":"2009-04-02T14:14:18Z","timestamp":1238681658000},"source":"Crossref","is-referenced-by-count":21,"title":["Evaluation of the in vitro skin permeation of antiviral drugs from penciclovir 1% cream and acyclovir 5% cream used to treat herpes simplex virus infection"],"prefix":"10.1186","volume":"9","author":[{"given":"Nathalie","family":"Hasler-Nguyen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donald","family":"Shelton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gilbert","family":"Ponard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marlene","family":"Bader","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martina","family":"Schaffrik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pascal","family":"Mallefet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,4,2]]},"reference":[{"key":"84_CR1","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1128\/AAC.31.3.361","volume":"31","author":"D Gold","year":"1987","unstructured":"Gold D, Corey L: Acyclovir Prophylaxis for Herpes Simplex Virus Infection. Antimicrob Agents Chemother 1987, 31: 361\u2013367.","journal-title":"Antimicrob Agents Chemother"},{"key":"84_CR2","first-page":"310","volume":"8","author":"R Hamuy","year":"1998","unstructured":"Hamuy R, Berman B: Treatment of Herpes Simplex Virus Infections With Topical Antiviral Agents. Eur J Dermatol 1998, 8: 310\u2013319.","journal-title":"Eur J Dermatol"},{"key":"84_CR3","doi-asserted-by":"publisher","first-page":"303","DOI":"10.14219\/jada.archive.2002.0169","volume":"133","author":"GW Raborn","year":"2002","unstructured":"Raborn GW, Martel AY, Lassonde M, Lewis MA, Boon R, Spruance SL: Effective Treatment of Herpes Simplex Labialis With Penciclovir Cream: Combined Results of Two Trials. J Am Den Assoc 2002, 133: 303\u2013309.","journal-title":"J Am Den Assoc"},{"key":"84_CR4","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1001\/jama.1997.03540410052030","volume":"277","author":"SL Spruance","year":"1997","unstructured":"Spruance SL, Rea TL, Thoming C, Tucker R, Saltzman R, Boon R: Penciclovir Cream for the Treatment of Herpes Simplex Labialis. A Randomized, Multicenter, Double-Blind, Placebo-Controlled Trial. Topical Penciclovir Collaborative Study Group. JAMA 1997, 277: 1374\u20131379. 10.1001\/jama.277.17.1374","journal-title":"JAMA"},{"key":"84_CR5","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1006\/viro.1997.8484","volume":"230","author":"RJ Visalli","year":"1997","unstructured":"Visalli RJ, Courtney RJ, Meyers C: Infection and Replication of Herpes Simplex Virus Type 1 in an Organotypic Epithelial Culture System. Virology 1997, 230: 236\u2013243. 10.1006\/viro.1997.8484","journal-title":"Virology"},{"issue":"6","key":"84_CR6","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1023\/B:PHAM.0000029277.60760.43","volume":"21","author":"CA Jarvis","year":"2004","unstructured":"Jarvis CA, McGuigan C, Heard CM: In Vitro Delivery of Novel, Highly Potent Anti-Varicella Zoster Virus Nucleoside Analogues to Their Target Site in the. Pharm Res 2004,21(6):914\u2013919. 10.1023\/B:PHAM.0000029277.60760.43","journal-title":"Pharm Res"},{"key":"84_CR7","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/jid.1962.129","volume":"39","author":"FN Marzulli","year":"1962","unstructured":"Marzulli FN: Barriers to Skin Penetration. J Invest Dermatol 1962, 39: 387\u2013393.","journal-title":"J Invest Dermatol"},{"key":"84_CR8","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1517\/13543784.12.2.165","volume":"12","author":"G Kleymann","year":"2003","unstructured":"Kleymann G: Novel Agents and Strategies to Treat Herpes Simplex Virus Infections. Expert Opin Investig Drugs 2003, 12: 165\u2013183. 10.1517\/13543784.12.2.165","journal-title":"Expert Opin Investig Drugs"},{"key":"84_CR9","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1046\/j.0022-202x.2001.01688.x","volume":"118","author":"H Wagner","year":"2002","unstructured":"Wagner H, Kostka KH, Lehr CM, Schaefer UF: Human Skin Penetration of Flufenamic Acid: in Vivo\/in Vitro Correlation (Deeper Skin Layers) for Skin Samples From the Same Subject. J Invest Dermatol 2002, 118: 540\u2013544. 10.1046\/j.0022-202x.2001.01688.x","journal-title":"J Invest Dermatol"},{"key":"84_CR10","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1002\/jps.2600751012","volume":"75","author":"RH Guy","year":"1986","unstructured":"Guy RH, Carlstrom EM, Bucks DA, Hinz RS, Maibach HI: Percutaneous Penetration of Nicotinates: in Vivo and in Vitro Measurements. J Pharm Sci 1986, 75: 968\u2013972. 10.1002\/jps.2600751012","journal-title":"J Pharm Sci"},{"key":"84_CR11","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1023\/A:1007648807195","volume":"17","author":"H Wagner","year":"2000","unstructured":"Wagner H, Kostka KH, Lehr CM, Schaefer UF: Drug Distribution in Human Skin Using Two Different in Vitro Test Systems: Comparison With in Vivo Data. Pharm Res 2000, 17: 1475\u20131481. 10.1023\/A:1007648807195","journal-title":"Pharm Res"},{"key":"84_CR12","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1111\/j.1365-4362.1983.tb02187.x","volume":"22","author":"TJ Franz","year":"1983","unstructured":"Franz TJ: Kinetics of Cutaneous Drug Penetration. Int J Dermatol 1983, 22: 499\u2013505. 10.1111\/j.1365-4362.1983.tb02187.x","journal-title":"Int J Dermatol"},{"key":"84_CR13","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/S0939-6411(01)00166-7","volume":"52","author":"K Moser","year":"2001","unstructured":"Moser K, Kriwet K, Naik A, Kalia YN, Guy RH: Passive Skin Penetration Enhancement and Its Quantification in Vitro. Eur J Pharm Biopharm 2001, 52: 103\u2013112. 10.1016\/S0939-6411(01)00166-7","journal-title":"Eur J Pharm Biopharm"},{"key":"84_CR14","first-page":"137","volume-title":"In Vitro Percutaneous Absorption: principles, Fundamentals and Applications","author":"A Rolland","year":"1991","unstructured":"Rolland A: Localization of Drugs in the Skin. In In Vitro Percutaneous Absorption: principles, Fundamentals and Applications. Edited by: Bronaugh RL, Maibach HI. CRC Press Boca Raton; 1991:137\u2013156."},{"key":"84_CR15","first-page":"1","volume-title":"Karger Basel","author":"H Schaefer","year":"1996","unstructured":"Schaefer H, Redelmeier TE: Structure and Dynamics of the skin barrier. Skin barrier: Principles of Percutaneous Absorption. Karger Basel 1996, 1\u201342."},{"key":"84_CR16","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1002\/jps.2600751115","volume":"75","author":"RL Bronaugh","year":"1986","unstructured":"Bronaugh RL, Stewart RF, Simon M: Methods for in Vitro Percutaneous Absorption Studies. VII: Use of Excised Human Skin. J Pharm Sci 1986, 75: 1094\u20131097. 10.1002\/jps.2600751115","journal-title":"J Pharm Sci"},{"key":"84_CR17","unstructured":"Skin Absorption \u2013 In Vitro Method. OECD [Organisation for Economic Cooperation and Development]. Guideline 428 2004."},{"key":"84_CR18","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1080\/10629360310001673917","volume":"4","author":"P Ertl","year":"2003","unstructured":"Ertl P, Muhlbacher J, Rohde B, Selzer P: Web-Based Cheminformatics and Molecular Property Prediction Tools Supporting Drug Design and Development at Novartis. SAR QSAR Environ Res 2003, 4: 321\u2013328. 10.1080\/10629360310001673917","journal-title":"SAR QSAR Environ Res"},{"key":"84_CR19","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1081\/CUS-120001870","volume":"20","author":"C Surber","year":"2001","unstructured":"Surber C, Schwarb FP, Smith EW: Tape-Stripping Technique. J Toxicol Cut & Ocular Toxicol 2001, 20: 461\u2013474. 10.1081\/CUS-120001870","journal-title":"J Toxicol Cut & Ocular Toxicol"},{"key":"84_CR20","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.addr.2003.10.025","volume":"56","author":"AC Williams","year":"2004","unstructured":"Williams AC, Barry BW: Penetration Enhancers. Adv Drug Deliv Rev 2004, 56: 603\u2013618. 10.1016\/j.addr.2003.10.025","journal-title":"Adv Drug Deliv Rev"},{"key":"84_CR21","doi-asserted-by":"publisher","first-page":"47","DOI":"10.2165\/00128071-200203010-00005","volume":"3","author":"B Brazzini","year":"2002","unstructured":"Brazzini B, Pimpinelli N: New and Established Topical Corticosteroids in Dermatology: Clinical Pharmacology and Therapeutic Use. Am J Clin Dermatol 2002, 3: 47\u201358. 10.2165\/00128071-200203010-00005","journal-title":"Am J Clin Dermatol"},{"key":"84_CR22","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1159\/000211511","volume":"10","author":"GK Menon","year":"1997","unstructured":"Menon GK, Elias PM: Morphologic Basis for a Pore-Pathway in Mammalian Stratum Corneum. Skin Pharmacol 1997, 10: 235\u2013246. 10.1159\/000211511","journal-title":"Skin Pharmacol"},{"key":"84_CR23","first-page":"723","volume":"27","author":"JVan de Sandt","year":"1999","unstructured":"Sandt J, Roguet R, Cohen C, Esdaile D, Ponec M, Corsini E, Barker C, Fusenig N, Liebsch M, Benford D, de Brugerolles de Fraissinette A, Fartasch M: The Use of Human keratinocytes and Human Skin Models for Predicting Skin Irritation. Atla 1999, 27: 723\u2013743.","journal-title":"Atla"},{"key":"84_CR24","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1128\/AAC.36.9.2037","volume":"36","author":"A Weinberg","year":"1992","unstructured":"Weinberg A, Bate BJ, Masters HB, Schneider SA, Clark JC, Wren CG, Allaman JA, Levin MJ: In Vitro Activities of Penciclovir and Acyclovir Against Herpes Simplex Virus Types 1 and 2. Antimicrob Agents Chemother 1992, 36: 2037\u20132038.","journal-title":"Antimicrob Agents Chemother"},{"key":"84_CR25","doi-asserted-by":"publisher","first-page":"2747","DOI":"10.1128\/AAC.36.12.2747","volume":"36","author":"DL Earnshaw","year":"1992","unstructured":"Earnshaw DL, Bacon TH, Darlison SJ, Edmonds K, Perkins RM, Vere Hodge R: A Mode of Antiviral Action of Penciclovir in MRC-5 Cells Infected With Herpes Simplex Virus Type 1 (HSV-1), HSV-2, and Varicella-Zoster Virus. Antimicrob Agents Chemother 1992, 36: 2747\u20132757.","journal-title":"Antimicrob Agents Chemother"},{"key":"84_CR26","volume-title":"Antimicrobial agents-antiviral agents (nonretroviral)","author":"FG Hayden","year":"2001","unstructured":"Hayden FG: Antimicrobial agents-antiviral agents (nonretroviral). Tenth edition. Mc Graw Hill Medical Publishing Division New-York, Chicago, San Francisco, Lisbon, London, Madrid, Mexico City, New Delhi, San Juan, Seoul, Singapore, Sidney, Toronto; 2001.","edition":"Tenth"},{"key":"84_CR27","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/S0195-6701(96)90010-9","volume":"33","author":"P Reusser","year":"1996","unstructured":"Reusser P: Herpesvirus Resistance to Antiviral Drugs: a Review of the Mechanisms, Clinical Importance and Therapeutic Options. J Hosp Infect 1996, 33: 235\u2013248. 10.1016\/S0195-6701(96)90010-9","journal-title":"J Hosp Infect"},{"key":"84_CR28","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1023\/A:1011904921318","volume":"15","author":"RC Wester","year":"1998","unstructured":"Wester RC, Christoffel J, Hartway T, Poblete N, Maibach HI, Forsell J: Human cadaver skin viability for in vitro percutaneous absorption: storage and detrimental effects of heat-separation and freezing. Pharm Res 1998, 15: 82\u201384. 10.1023\/A:1011904921318","journal-title":"Pharm Res"}],"container-title":["BMC Dermatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-5945-9-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-5945-9-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-5945-9-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,7,5]],"date-time":"2016-07-05T02:04:22Z","timestamp":1467684262000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcdermatol.biomedcentral.com\/articles\/10.1186\/1471-5945-9-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4,2]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["84"],"URL":"https:\/\/doi.org\/10.1186\/1471-5945-9-3","relation":{},"ISSN":["1471-5945"],"issn-type":[{"value":"1471-5945","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,4,2]]},"article-number":"3"}}